These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18388118)

  • 1. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
    Viron B; Dupuy CA; Kolta A; Casadevall N
    Nephrol Dial Transplant; 2008 Jul; 23(7):2416-8. PubMed ID: 18388118
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.
    Summers SA; Matijevic A; Almond MK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2137-9. PubMed ID: 15252175
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
    Howman R; Kulkarni H
    Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
    Katagiri D; Shibata M; Katsuki T; Masumoto S; Katsuma A; Minami E; Hoshino T; Inoue T; Tada M; Hinoshita F
    Clin Exp Nephrol; 2010 Oct; 14(5):501-5. PubMed ID: 20652821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.
    Asari A; Gokal R
    J Am Soc Nephrol; 2004 Aug; 15(8):2204-7. PubMed ID: 15284306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.
    Jacob A; Sandhu K; Nicholas J; Jones H; Odum J; Rylance P; Carmichael P; Jackson M; Handa S; Macwhannell A; Basu S; Wahid F; Casadevall N; Mufti G; Macdougall I
    Nephrol Dial Transplant; 2006 Oct; 21(10):2963-5. PubMed ID: 16861239
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
    Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
    J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoetin-induced autoimmune pure red cell aplasia.
    Casadevall N
    Hematol J; 2004; 5 Suppl 3():S104-9. PubMed ID: 15190289
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
    Lim SK; Bee PC; Keng TC; Chong YB
    Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.
    Jöbsis JJ; Fijnvandraat K; Stapel SO; Bouts AH
    Pediatr Nephrol; 2010 May; 25(5):993-4. PubMed ID: 20165889
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosimilar epoetins.
    Macdougall IC
    Nephrol Dial Transplant; 2009 May; 24(5):1698-9; author reply 1699-700. PubMed ID: 19366858
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red cell aplasia secondary to erythropoietin therapy.
    Edwards GM; Alejmi AA
    Clin Med (Lond); 2024 Jul; 24(4):100229. PubMed ID: 39029801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration.
    Shinohara K
    Am J Hematol; 2007 Mar; 82(3):247-8. PubMed ID: 16947314
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
    Mattison P; Upadhyay K; Wilcox JE; Moudgil A; Silverstein DM
    Pediatr Nephrol; 2010 May; 25(5):971-6. PubMed ID: 20091055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Hashimoto K; Harada M; Kamijo Y
    Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies.
    Fraer M; Campbell A; Sawaya BP
    Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
    Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
    Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.